berberine has been researched along with Acute Coronary Syndrome in 1 studies
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1." | 6.77 | Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. ( Cao, JT; Huang, ZQ; Li, YG; Meng, S; Sun, YG; Wang, CQ; Wang, LS; Zhou, Q, 2012) |
| "1." | 2.77 | Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. ( Cao, JT; Huang, ZQ; Li, YG; Meng, S; Sun, YG; Wang, CQ; Wang, LS; Zhou, Q, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, S | 1 |
| Wang, LS | 1 |
| Huang, ZQ | 1 |
| Zhou, Q | 1 |
| Sun, YG | 1 |
| Cao, JT | 1 |
| Li, YG | 1 |
| Wang, CQ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention[NCT03378934] | Phase 4 | 64 participants (Anticipated) | Interventional | 2018-09-26 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for berberine and Acute Coronary Syndrome
| Article | Year |
|---|---|
Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroid | 2012 |